SCHEMBL1409158

SCHEMBL1409158

CCC(C)CCCCCCCCCCCCO

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 3/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.41
ACE2 Q9BYF1 1/20 0.39
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
PRKCA P17252 1/20 0.34
PRKCH P24723 1/20 0.34
PRKCI P41743 1/20 0.34
PRKCE Q02156 1/20 0.34
PRKCQ Q04759 1/20 0.34
PRKCZ Q05513 1/20 0.34
PRKCD Q05655 1/20 0.34
PRKD1 Q15139 1/20 0.34
SPHK1 Q9NYA1 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4288193 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL1658874 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL352274 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL345863 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL9488487 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL3772105 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL352447 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL4779607 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL1658809 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL351960 1.00 LMNA (0.46) LMNAALDH1A1TSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118056015-A Biotechnological production method of aldehyde mixture 西姆莱斯有限公司 2024-05-17 CN claimed
EP-0898609-B1 MID-CHAIN BRANCHED PRIMARY ALKYL SULPHATES AS SURFACTANTS PROCTER & GAMBLE (US) 2002-10-09 EP claimed
EP-0898606-B1 MID-CHAIN BRANCHED PRIMARY ALKYL ALKOXYLATED SULPHATE SURFACTANTS PROCTER & GAMBLE (US) 2001-12-12 EP claimed
US-6153577-A USEFUL IN LAUNDRY AND CLEANING COMPOSITIONS; GRANULAR AND LIQUID DETERGENTS THE PROCTER & GAMBLE COMPANY (US) 2000-11-28 US claimed
US-6008181-A LAUNDRY AND CLEANING COMPOSITIONS USING AT LOW WATER TEMPERATURE WASHING THE PROCTER & GAMBLE COMPANY (US) 1999-12-28 US claimed
EP-0944699-A2 POLYOXYALKYLENE SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 EP claimed
EP-0898606-A1 MID-CHAIN BRANCHED PRIMARY ALKYL ALKOXYLATED SULPHATE SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1999-03-03 EP claimed
WO-1998023712-A2 POLYOXYALKYLENE SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 WO claimed
WO-1997039087-A1 MID-CHAIN BRANCHED PRIMARY ALKYL ALKOXYLATED SULPHATE SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1997-10-23 WO claimed
EP-4611717-A1 COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS L'OREAL (FR) 2025-09-10 EP disclosed
US-20240199998-A1 FABRIC TREATMENT COMPOSITIONS COMPRISING BENEFIT AGENT CAPSULES PROCTER & GAMBLE (US) 2024-06-20 US disclosed
US-20240199992-A1 FABRIC TREATMENT COMPOSITIONS COMPRISING BENEFIT AGENT CAPSULES PROCTER & GAMBLE (US) 2024-06-20 US disclosed
CN-118056015-A Biotechnological production method of aldehyde mixture 西姆莱斯有限公司 2024-05-17 CN disclosed
US-20240156703-A1 COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS L'OREAL (FR) 2024-05-16 US disclosed
WO-1997039087-A1 MID-CHAIN BRANCHED PRIMARY ALKYL ALKOXYLATED SULPHATE SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1997-10-23 WO disclosed
WO-1997039091-A1 MID-CHAIN BRANCHED SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1997-10-23 WO disclosed
WO-1997039089-A1 LIQUID CLEANING COMPOSITIONS CONTAINING SELECTED MID-CHAIN BRANCHED SURFACTANTS THE PROCTER & GAMBLE COMPANY (US) 1997-10-23 WO disclosed
WO-1997038972-A1 PROCESS FOR MANUFACTURING SULPHATES OF LONGER CHAIN BRANCHED ALKANOLS AND ALKOXYLATED ALKANOLS THE PROCTER & GAMBLE COMPANY (US) 1997-10-23 WO disclosed
US-5162304-A Higher Isoalkyl Alcohols DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1992-11-10 US disclosed
EP-0452941-A2 Use of isomonools in the treatment and prophylaxis of cancer DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1991-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240156703-A1 COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS KRT18, TUBB2B, TUBB LMNA 151/4885ALDH1A1 2427/4885TSHR 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.